Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeability conditions
Authors:
Open Access
- 19 March 2024
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 63 (5) , 107150
Abstract
No abstract availableKeywords
Funding Information
- Xunta de Galicia
- CIBERINFEC
- Instituto de Salud Carlos III
This publication has 26 references indexed in Scilit:
- In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modificationInternational Journal of Antimicrobial Agents, 2023
- Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coliInternational Journal of Antimicrobial Agents, 2023
- Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis—ReplyJAMA, 2023
- Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from SpainInternational Journal of Antimicrobial Agents, 2023
- In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolatesJournal of Global Antimicrobial Resistance, 2023
- Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactamClinical Microbiology and Infection, 2022
- In vitroevolution of cefepime/zidebactam (WCK 5222) resistance inPseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact onin vivoefficacyJournal of Antimicrobial Chemotherapy, 2021
- Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing EnterobacteralesJournal of Antimicrobial Chemotherapy, 2021
- Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combinationExpert Review of Anti-infective Therapy, 2020
- Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamasesJournal of Medicinal Chemistry, 2020